Kennedy Capital Management LLC Purchases 107,766 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

Kennedy Capital Management LLC raised its stake in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 59.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 289,286 shares of the technology company's stock after acquiring an additional 107,766 shares during the period. Kennedy Capital Management LLC owned approximately 1.44% of Simulations Plus worth $8,068,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of SLP. Conestoga Capital Advisors LLC lifted its position in shares of Simulations Plus by 15.0% during the fourth quarter. Conestoga Capital Advisors LLC now owns 2,226,262 shares of the technology company's stock worth $62,090,000 after purchasing an additional 290,414 shares during the last quarter. Royce & Associates LP raised its stake in shares of Simulations Plus by 56.6% in the fourth quarter. Royce & Associates LP now owns 371,797 shares of the technology company's stock worth $10,369,000 after purchasing an additional 134,381 shares during the last quarter. Nicholas Company Inc. acquired a new stake in shares of Simulations Plus in the fourth quarter worth $3,418,000. JPMorgan Chase & Co. lifted its holdings in shares of Simulations Plus by 210.7% in the 4th quarter. JPMorgan Chase & Co. now owns 147,154 shares of the technology company's stock valued at $4,104,000 after buying an additional 99,789 shares during the period. Finally, Summitry LLC acquired a new stake in shares of Simulations Plus during the 4th quarter worth approximately $2,385,000. 78.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $33.91, for a total transaction of $678,200.00. Following the completion of the transaction, the director now directly owns 3,402,584 shares in the company, valued at approximately $115,381,623.44. This trade represents a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 19.40% of the stock is currently owned by corporate insiders.

Simulations Plus Stock Down 0.4 %

NASDAQ SLP traded down $0.12 during trading hours on Wednesday, hitting $32.69. The company had a trading volume of 202,099 shares, compared to its average volume of 190,581. Simulations Plus, Inc. has a fifty-two week low of $23.01 and a fifty-two week high of $51.22. The firm has a market cap of $657.43 million, a P/E ratio of 81.73 and a beta of 1.13. The business has a fifty day simple moving average of $28.79 and a 200-day simple moving average of $30.06.

Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its quarterly earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. The company had revenue of $22.43 million during the quarter, compared to the consensus estimate of $21.93 million. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. The business's quarterly revenue was up 22.5% on a year-over-year basis. During the same period last year, the business earned $0.20 EPS. Equities analysts forecast that Simulations Plus, Inc. will post 1.09 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on SLP. KeyCorp boosted their price target on shares of Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a research report on Wednesday. William Blair reaffirmed an "outperform" rating on shares of Simulations Plus in a research report on Wednesday, January 8th. Finally, StockNews.com downgraded Simulations Plus from a "hold" rating to a "sell" rating in a report on Monday. One research analyst has rated the stock with a sell rating, one has given a hold rating, five have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $50.00.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.